@article{Appleman_2021,<br/><span class="tab"></span> title={KEYNOTE-365 cohort B: Pembrolizumab (pembro) plus docetaxel and prednisone in abiraterone (abi) or enzalutamide (enza)–pretreated patients with metastatic castration-resistant prostate cancer (mCRPC)—New data after an additional 1 year of follow-up.},<br/><span class="tab"></span> volume={39},<br/><span class="tab"></span> ISSN={1527-7755},<br/><span class="tab"></span> url={http://dx.doi.org/10.1200/jco.2021.39.6_suppl.10},<br/><span class="tab"></span> DOI={10.1200/jco.2021.39.6_suppl.10},<br/><span class="tab"></span> number={6_suppl},<br/><span class="tab"></span> journal={Journal of Clinical Oncology},<br/><span class="tab"></span> publisher={American Society of Clinical Oncology (ASCO)},<br/><span class="tab"></span> author={Appleman,<br/><span class="tab"></span> Leonard Joseph and Kolinsky,<br/><span class="tab"></span> Michael Paul and Berry,<br/><span class="tab"></span> William R. and Retz,<br/><span class="tab"></span> Margitta and Mourey,<br/><span class="tab"></span> Loic and Piulats,<br/><span class="tab"></span> Josep M. and Romano,<br/><span class="tab"></span> Emanuela and Gravis,<br/><span class="tab"></span> Gwenaelle and Gurney,<br/><span class="tab"></span> Howard and De Bono,<br/><span class="tab"></span> Johann S. and Boegemann,<br/><span class="tab"></span> Martin and Emmenegger,<br/><span class="tab"></span> Urban and Joshua,<br/><span class="tab"></span> Anthony M. and Massard,<br/><span class="tab"></span> Christophe and Sridhar,<br/><span class="tab"></span> Srikala S. and Conter,<br/><span class="tab"></span> Henry Jacob and Li,<br/><span class="tab"></span> Xin Tong and Schloss,<br/><span class="tab"></span> Charles and Poehlein,<br/><span class="tab"></span> Christian Heinrich and Yu,<br/><span class="tab"></span> Evan Y.},<br/><span class="tab"></span> year={2021},<br/><span class="tab"></span> month=feb,<br/><span class="tab"></span> pages={10–10} }